Sylvia S. Ng, Ph.D.

2002 University of Toronto, Toronto, ON, Canada 
Pharmacology, Oncology
"Sylvia Ng"
Mean distance: (not calculated yet)


Sign in to add mentor
David Hedley grad student 2002 University of Toronto
 (Preclinical evaluation of inhibitors of the phosphatidylinositide 3-kinase/protein kinase B cell survival pathway in the treatment of pancreatic cancer.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ng SS, Tsao MS, Nicklee T, et al. (2002) Effects of the epidermal growth factor receptor inhibitor OSI-774, Tarceva, on downstream signaling pathways and apoptosis in human pancreatic adenocarcinoma. Molecular Cancer Therapeutics. 1: 777-83
Ng SS, Tsao MS, Nicklee T, et al. (2001) Wortmannin inhibits pkb/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 3269-75
Ng SSW, Tsao MS, Chow S, et al. (2000) Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. Cancer Research. 60: 5451-5
See more...